Martin E. Gordon, M.D., a distinguished member of the Yale School of Medicine’s class of 1946 and a clinical professor of medicine, has been awarded the Dean’s Peter Parker Medal for outstanding contributions to medicine and the well being of the Yale...
Susan E. Hardy, M.D., instructor in geriatric medicine at Yale School of Medicine, was recently awarded a 2004 Pfizer/Foundation for Health in Aging Junior Faculty Scholar Award for Research on Health Outcomes in Geriatrics. Hardy will receive $65,000...
Linking brain research and child development is the theme of the Comer School Development Program (SDP) 35th anniversary celebration banquet and symposium October 11 at 4 p.m. and October 12 from 8:30 a.m. to 3:30 p.m. at the Omni New Haven Hotel at Yale...
The Yale School of Medicine recently hosted a special program of neuroscience lectures and unveiled a plaque at the heart of the medical campus to honor Bristol-Myers Squibb Company for its contributions to biomedical research and education at Yale....
Black and Hispanic patients experience marked delays in heart attack treatment compared with whites, Yale researchers report in an article published in the October 6 Journal of the American Medical Association (JAMA). The study of approximately 110,000...
The rate of diabetes among persons taking certain newer anti-psychotic medications is higher than that found in the general population, Yale researchers report in a study in the American Journal of Psychiatry. The study followed patients with...
Yale researchers report the first explanation of the physiological basis for the inherited, chronic pain syndrome erythromelalgia in an article today in the Journal of Neuroscience. Erythromelalgia has largely remained an obscure disease with unknown...
In a whole new approach to asthma research, scientists at Yale have discovered that a molecule called Vascular Endothelial Growth Factor (VEGF) likely plays an important role in the development of the disease and raises the possibility of new asthma...
The National Cancer Institute recently awarded a five-year, $7.5 million program project grant to investigators at the Yale School of Medicine to continue studies on the role of viruses and mutant cellular proteins in tumorigenic transformation of cells...
Yale researcher Robert S. Sherwin, the C.N.H. Long Professor of Internal Medicine at Yale School of Medicine, is one of four physician-scientists recognized by Novartis Pharmaceuticals for significant and innovative research, clinical practice advances...
